With federal public health agencies under the helm of Robert F. Kennedy Jr., a longtime vaccine critic, the usual schedule ...

Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is conducting a study titled Retrospective Study Evaluating ...

How you can make sure you get your RSV vaccine this winterThe UK is the first country to offer a RSV vaccine to help save the ...

RSV usually only has mild symptoms, but it can lead to breathing problems in the most vulnerable infants. The vaccine is ...

Palivizumab was the only approved therapy to prevent severe RSV disease in infants and young children until the approval of nirsevimab in 2023.

With COVID-19 hospitalizations rising and flu and RSV on the horizon, experts say it’s time to boost up your immunity ahead of the fall and winter season. Here are answers to some frequently ...

In babies, RSV is a common cause of a type of chest infection called bronchiolitis. Last week, the UK Health Security Agency ...

Inpatient mortality and adverse outcomes were significantly more likely among adults hospitalized with RSV infection vs seasonal influenza.

RSV hospitalization was associated with increased risk for new CVEs and worsening of preexisting cardiovascular conditions.

RSV season is ramping up, and doctors are hoping a new shot to prevent the virus in young children will ease the caseload this year. However, some pediatricians are facing challenges getting supply.

No RSV vaccine has been approved by the Food and Drug Administration, but the first attempt was made in the 1960s, which was unsuccessful as it led to severe and lethal cases of lung inflammatory ...

RSV infections of the lungs and airways send up to 160,000 older adults to the hospital each year, at an annual cost of more than $1.3 billion, according to the Michigan Medicine report.